-
Two-stage approach for risk estimation of fetal trisomy 21 and other aneuploidies using computational intelligence systems.
Neocleous AC, Syngelaki A, Nicolaides KH, Schizas CN.
Ultrasound Obstet Gynecol 2018;51:503-508. pdf -
Intelligent Non-invasive Diagnosis of Aneuploidy: Raw Values and Highly Imbalanced Dataset.
Neocleous A, Nicolaides K, Schizas C.
IEEE J Biomed Health Inform 2017;21:1271-1279. pdf -
First Trimester Noninvasive Prenatal Diagnosis: A Computational Intelligence Approach.
Neocleous AC, Nicolaides KH, Schizas CN.
IEEE J Biomed Health Inform 2016;20:1427-38. pdf -
Meta-analysis of second-trimester markers for trisomy 21.
Agathokleous M, Chaveeva P, Poon LC, Kosinski P, Nicolaides KH.
Ultrasound Obstet Gynecol 2013;41:247-61. -
Screening at 11-13+6 weeks' gestation.
Sonek JD, Nicolaides KH, Janku P.
Ceska Gynekol 2012;77:92-104. -
Nasal bone assessment in fetuses with trisomy 21 at 16-24 weeks of gestation by three-dimensional ultrasound.
Persico N, Molina F, Azumendi G, Fedele L, Nicolaides KH.
Prenat Diagn 2012;32:240-4. -
Posterior brain in fetuses with trisomy 18, trisomy 13 and triploidy at 11 to 13 weeks' gestation.
Ferreira AF, Syngelaki A, Smolin A, Vayna AM, Nicolaides KH.
Prenat Diagn 2012;13:1-5. -
Screening for fetal aneuploidies at 11 to 13 weeks.
Nicolaides KH.
Prenat Diagn 2011;31:7-15. -
A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment.
Nicolaides KH.
Prenat Diagn 2011;31:3-6. -
Detecting open spina bifida at the 11-13-week scan by assessing intracranial translucency and the posterior brain region: mid-sagittal or axial plane?
Chaoui R, Nicolaides KH.
Ultrasound Obstet Gynecol 2011;38:609-12. -
Additional first-trimester ultrasound markers.
Sonek J, Nicolaides K.
Clin Lab Med 2010;30:573-92. -
Nasal bone length in euploid fetuses at 16-24 weeks of gestation by three-dimensional ultrasound.
Persico N, Molina F, Borenstein M, Azumendi G, Nicolaides KH.
Ultrasound Obstet Gynecol 2010;36:285-90. -
From nuchal translucency to intracranial translucency: towards the early detection of spina bifida.
Chaoui R, Nicolaides KH.
Ultrasound Obstet Gynecol 2010;35:133-8. -
Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation.
Kagan KO, Cicero S, Staboulidou I, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2009;33:259-64. -
Assessment of intracranial translucency (IT) in the detection of spina bifida at the 11-13-week scan.
Chaoui R, Benoit B, Mitkowska-Wozniak H, Heling KS, Nicolaides KH.
Ultrasound Obstet Gynecol 2009;34:249-52. -
First-trimester screening for trisomy 21 using nuchal translucency and nasal bone evaluations in a selected and an unselected population.
Sonek J, Cicero S, Nicolaides K.
Am J Obstet Gynecol 2007;196:19. -
Some thoughts on the true value of ultrasound.
Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:671-4. -
Nasal bone assessment in prenatal screening for trisomy 21.
Sonek JD, Cicero S, Neiger R, Nicolaides KH.
Am J Obstet Gynecol 2006;195:1219-30. -
Nasal bone in first-trimester screening for trisomy 21.
Cicero S, Avgidou K, Rembouskos G, Kagan KO, Nicolaides KH.
Am J Obstet Gynecol 2006;195:109-14. -
Assessment of the gap between the fetal nasal bones at 11 to 13 + 6 weeks of gestation by three-dimensional ultrasound.
Peralta CF, Falcon O, Wegrzyn P, Faro C, Nicolaides KH.
Ultrasound Obstet Gynecol 2005;25:464-7.